Clinical stability is the first step of clinical improvement in patients with pneumonia. Clinical stability has been proven to be useful in guiding the switch of antibiotic therapy from intravenous to oral formulations. Given its importance in patient management, several sets of criteria have been created to standardise its definition. However, a single set of criteria cannot fit everybody; therefore, a personalised approach based on the resolution of the patient's most prominent clinical features should be considered. Moreover, it is important to choose the set of criteria that best fits the standard of care at each site of practice. Clinical failure is considered a predictive factor of adverse clinical outcomes. The identification of the ...
SETTING: A total of 33 hospitals in 13 countries in North America, Europe, Africa, Asia and Latin Am...
Background: Adverse outcomes after discharge in patients hospitalized for community-acquired pneumon...
Background: The etiology of clinical failure in hospitalized patients with community-acquired pneumo...
Once antibiotics have been started in patients with community-acquired pneumonia (CAP), the evaluati...
SummaryCommunity-acquired pneumonia (CAP) is a curable disease. Both the European and American clini...
For patients with community-acquired pneumonia (CAP), clinical response during the first days of tre...
[eng] Treatment failure in community-acquired pneumonia (CAP) is the failure to normalize the clinic...
Community acquired pneumonia (CAP) is the leading infectious cause of mortality worldwide with appro...
AbstractA number of different methods exist to assess clinical stability, a key component of pneumon...
ABSTRACTFor patients with community-acquired pneumonia (CAP), clinical response during the first day...
SummaryBackgroundA clinical stability (CS) evaluation is thought to be important in community-acquir...
Assessment of early response to treatment is crucial for the management of community-acquired pneumo...
Assessment of early response to treatment is crucial for the management of community-acquired pneumo...
International audienceImportance: Failure of treatment is the most serious complication in community...
INTRODUCTION: Treatment failure in community-acquired-pneumonia (CAP) patients is associated with a ...
SETTING: A total of 33 hospitals in 13 countries in North America, Europe, Africa, Asia and Latin Am...
Background: Adverse outcomes after discharge in patients hospitalized for community-acquired pneumon...
Background: The etiology of clinical failure in hospitalized patients with community-acquired pneumo...
Once antibiotics have been started in patients with community-acquired pneumonia (CAP), the evaluati...
SummaryCommunity-acquired pneumonia (CAP) is a curable disease. Both the European and American clini...
For patients with community-acquired pneumonia (CAP), clinical response during the first days of tre...
[eng] Treatment failure in community-acquired pneumonia (CAP) is the failure to normalize the clinic...
Community acquired pneumonia (CAP) is the leading infectious cause of mortality worldwide with appro...
AbstractA number of different methods exist to assess clinical stability, a key component of pneumon...
ABSTRACTFor patients with community-acquired pneumonia (CAP), clinical response during the first day...
SummaryBackgroundA clinical stability (CS) evaluation is thought to be important in community-acquir...
Assessment of early response to treatment is crucial for the management of community-acquired pneumo...
Assessment of early response to treatment is crucial for the management of community-acquired pneumo...
International audienceImportance: Failure of treatment is the most serious complication in community...
INTRODUCTION: Treatment failure in community-acquired-pneumonia (CAP) patients is associated with a ...
SETTING: A total of 33 hospitals in 13 countries in North America, Europe, Africa, Asia and Latin Am...
Background: Adverse outcomes after discharge in patients hospitalized for community-acquired pneumon...
Background: The etiology of clinical failure in hospitalized patients with community-acquired pneumo...